Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
INVO Fertility ( (IVF) ) has issued an update.
On May 28, 2025, INVO Fertility entered into several agreements with NTI and other entities, involving exchanges and conversions of shares and securities. These agreements include the NTI Exchange Agreement, the issuance of a secured convertible promissory note, and a security agreement, among others. The transactions are designed to restructure and manage the company’s financial instruments and obligations, potentially impacting its market positioning and shareholder value. Additionally, Dr. Daniel Teper resigned as President of the Company on the same date.
The most recent analyst rating on (IVF) stock is a Buy with a $2.00 price target. To see the full list of analyst forecasts on INVO Fertility stock, see the IVF Stock Forecast page.
Spark’s Take on IVF Stock
According to Spark, TipRanks’ AI Analyst, IVF is a Neutral.
INVO Fertility’s overall stock score reflects significant financial challenges despite revenue growth. The company’s high leverage and operational losses pose risks to financial stability. Mixed technical indicators and a poor valuation further contribute to a cautious outlook.
To see Spark’s full report on IVF stock, click here.
More about INVO Fertility
Average Trading Volume: 2,252,247
Technical Sentiment Signal: Sell
Current Market Cap: $3.72M
For detailed information about IVF stock, go to TipRanks’ Stock Analysis page.